We are live on ! Find out more
HT

HAP Trading Portfolio holdings

AUM $1.42B
1-Year Est. Return 41.92%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+41.92%
3 Year Est. Return
+140.6%
5 Year Est. Return
+193.92%
10 Year Est. Return
+737.23%
AUM
$1.83B
AUM Growth
+$599M
Cap. Flow
+$1.27B
Cap. Flow %
69.31%
Top 10 Hldgs %
41.89%
Holding
1,615
New
406
Increased
447
Reduced
335
Closed
413

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$257M
2
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$65.8M
3
HD icon
Home Depot
HD
+$30.2M
4
AMZN icon
Amazon
AMZN
+$28.4M
5
CSCO icon
Cisco
CSCO
+$27.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.4%
2 Consumer Discretionary 13.55%
3 Technology 9.86%
4 Energy 4.16%
5 Communication Services 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTN
26
DELISTED
Raytheon Company
RTN
$13.1M 0.72%
59,774
+24,230
+68% +$5.12M
AMZN icon
27
CALL
Amazon
AMZN
$2.92T
$12.3M 0.68%
1,264,000
+294,000
+30% +$26M
DIS icon
28
Walt Disney
DIS
$167B
$12.2M 0.67%
84,513
+67,918
+409% +$9.48M
ITCI
29
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12.2M 0.67%
637,100
+621,700
+4,037% +$7.46M
APH icon
30
Amphenol
APH
$198B
$12.2M 0.67%
+449,180
New +$11.5M
AXSM icon
31
CALL
Axsome Therapeutics
AXSM
$11.2B
$12M 0.66%
173,700
+160,600
+1,226% +$6.49M
LEN icon
32
Lennar Class A
LEN
$19.8B
$11.9M 0.65%
220,439
+52,458
+31% +$2.99M
OXY icon
33
Occidental Petroleum
OXY
$56.8B
$11.5M 0.63%
278,114
+234,922
+544% +$9.41M
CVNA icon
34
Carvana
CVNA
$68.6B
$10.3M 0.57%
560,340
+277,685
+98% +$4.65M
CVS icon
35
CVS Health
CVS
$133B
$10.3M 0.56%
+138,629
New +$9.73M
DD icon
36
DuPont de Nemours
DD
$18.5B
$9.96M 0.55%
+123,540
New +$10.3M
BA icon
37
Boeing
BA
$171B
$9.66M 0.53%
+29,643
New +$10.5M
GILD icon
38
Gilead Sciences
GILD
$162B
$9.65M 0.53%
148,528
+7,565
+5% +$493K
LVS icon
39
Las Vegas Sands
LVS
$31.7B
$9.43M 0.52%
136,650
+119,859
+714% +$7.48M
NKE icon
40
Nike
NKE
$61.9B
$9.24M 0.51%
+91,216
New +$8.6M
IEF icon
41
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$9.17M 0.5%
+83,200
New +$9.28M
PCG icon
42
PUT
PG&E
PCG
$38.3B
$8.41M 0.46%
2,794,500
+1,914,600
+218% +$16.4M
CVNA icon
43
CALL
Carvana
CVNA
$68.6B
$7.99M 0.44%
1,443,000
+132,000
+10% +$2.21M
EPC icon
44
Edgewell Personal Care
EPC
$1.25B
$7.87M 0.43%
254,146
-64,987
-20% -$2.1M
ON icon
45
ON Semiconductor
ON
$31.8B
$7.71M 0.42%
316,167
+22,706
+8% +$480K
WOLF icon
46
Wolfspeed
WOLF
$1.23B
$7.47M 0.41%
161,874
+3,006
+2% +$140K
DXCM icon
47
DexCom
DXCM
$31.5B
$7.2M 0.39%
+131,636
New +$6.24M
OKE icon
48
Oneok
OKE
$57.2B
$7.18M 0.39%
+94,875
New +$6.78M
GDS icon
49
CALL
GDS Holdings
GDS
$6.56B
$7.02M 0.38%
878,300
-534,600
-38% -$24M
LYB icon
50
LyondellBasell Industries
LYB
$20B
$6.7M 0.37%
70,885
+40,136
+131% +$3.68M

Similar funds

HAP Trading's Q4 2019 Portfolio in Review

As of Q4 2019, HAP Trading held 1,615 positions worth $1.83B, up 49% from $1.23B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

HAP Trading deployed $1.27B of net new capital in Q4 2019, opening 406 new positions and adding to 447 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,484,109 shares worth $288M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $21.3M trimmed.

  • HAP Trading's largest Q4 2019 buy was Bristol-Myers Squibb: 4,484,109 shares worth $288M.
  • HAP Trading added most to Gen Digital in Q4 2019, an estimated $21.7M increase.
  • HAP Trading's biggest Q4 2019 reduction was NXP Semiconductors, cutting an estimated $21.3M.
  • HAP Trading fully exited Humana in Q4 2019, selling an estimated $49.3M.
  • HAP Trading's ten largest holdings make up 42% of its $1.83B portfolio in Q4 2019.
  • HAP Trading opened 406 new positions and closed 413 in Q4 2019.
  • HAP Trading's portfolio value rose 49% quarter-over-quarter to $1.83B.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.